151
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Severe group A streptococcal infections in Uppsala County, Sweden: Clinical and molecular characterization of a case cluster from 2006 to 2007

, , , , , , , & show all
Pages 823-830 | Received 14 Mar 2009, Published online: 18 Nov 2009

References

  • Johnson DR, Kaplan EL, Van Gheem A, Facklam RR, Beal B. Characterization of group A streptococci (Streptococcus pyogenes): correlation of M-protein and emm gene type with T-protein agglutination pattern and serum opacity factor. J Med Microbiol 2006; 55: 157–64
  • Darenberg J, Luca-Harari B, Jasir A, Sandgren A, Pettersson H, Schalén C, et al. Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis 2007; 45: 450–8
  • Eriksson BK, Norgren M, McGregor K, Spratt BG, Henriques Normark B. Group A streptococcal infections in Sweden: a comparative study of invasive and noninvasive infections and analysis of dominant T28 emm28 isolates. Clin Infect Dis 2003; 37: 1189–93
  • Johnson DR, Wotton JT, Shet A, Kaplan EL. A comparison of group A streptococci from invasive and uncomplicated infections: are virulent clones responsible for serious streptococcal infections?. J Infect Dis 2002; 185: 1586–95
  • Muotiala A, Seppälä H, Huovinen P, Vuopio-Varkila J. Molecular comparison of group A streptococci of M1T1 serotype from invasive and non-invasive infections in Finland. J Infect Dis 1997; 175: 392–9
  • Svensson N, Öberg S, Henriques B, Holm S, Källenius G, Romanus V, et al. Invasive group A streptococcal infections in Sweden in 1994 and 1995: epidemiology and clinical spectrum. Scand J Infect Dis 2000; 32: 609–14
  • Kaplan EL, Wotton JT, Johnson DR. Dynamic epidemiology of group A streptococcal serotypes associated with pharyngitis. Lancet 2001; 358: 1334–7
  • Kotb M. Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev 1995; 8: 411–26
  • Hackett SP, Stevens DL. Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-beta synthesis. J Infect Dis 1993; 168: 232–5
  • Norrby-Teglund A, Chatellier S, Low DE, McGeer A, Green K, Kotb M. Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur J Immunol 2000; 30: 3247–55
  • Norrby-Teglund A, Thulin P, Gan BS, Kotb M, McGeer A, Andersson J, et al. Evidence for superantigen involvement in severe group A streptococcal tissue infections. J Infect Dis 2001; 184: 853–60
  • Proft T, Fraser JD. Bacterial superantigens. Clin Exp Immunol 2003; 133: 299–306
  • Kotb M, Norrby-Teglund A, McGeer A, El-Sherbini H, Dorak MT, Khurshid A, et al. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med 2002; 8: 1398–404
  • Basma H, Norrby-Teglund A, Guedez Y, McGeer A, Low DE, El-Ahmedy O, et al. Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. Infect Immun 1999; 67: 1871–7
  • Mascini EM, Jansze M, Schellekens JF, Musser JM, Faber JA, Verhoef-Verhage LA, et al. Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies. J Infect Dis 2000; 181: 631–8
  • Norrby-Teglund A, Pauksens K, Holm SE, Norgren M. Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease. J Infect 1994; 170: 585–91
  • Swedish Institute for Infectious Disease Control. Beta hemolytic group-A-streptococci (GAS) (invasive infection); 2007. Available at: www.smittskyddsinstitutet.se/in-english/statistics/beta-hemolytic-group-a-streptococci-gas-invasiv-infection/ accessed 19 June 2008.
  • Public Health Agency of Canada. Guidelines for the prevention and control of invasive group A streptococcal disease: definitions; 2009. Available at: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/06vol32/32s2/5-defs-eng.php accessed 25 June 2009.
  • The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome: rational and consensus definition. JAMA 1993; 269: 390–1
  • Jasir A, Tanna A, Efstratiou A, Schalén C. Unusual occurrence of M type 77, antibiotic-resistant group A streptococci in southern Sweden. J Clin Microbiol 2001; 39: 586–90
  • Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 1996; 34: 953–8
  • Centers for Disease Control and Prevention.Streptococcus pyogenes emm sequence database; 2006. Available at: http://www.cdc.gov/ncidod/biotech/strep/strepblast.htm accessed 22 June 2008.
  • Schmitz FJ, Beyer A, Charpentier E, Henriques Normark B, Schade M, Fluit AC, et al. Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates. J Infect Dis 2003; 188: 1578–86
  • Ekelund K, Darenberg J, Norrby-Teglund A, Hoffman S, Bang D, Skinhoj P, et al. Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study. J Clin Microbiol 2005; 43: 3101–9
  • Darenberg J, Söderquist B, Henriques Normark B, Norrby-Teglund A. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome. Clin Infect Dis 2004; 38: 836–42

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.